Cereno Scientific’s board proposes new board member Jeppe Øvlesen
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company’s board of directors proposes for Jeppe Øvlesen to be newly elected as a board member at the extraordinary general meeting on November 7, 2023. The board also proposes that the board of directors should include six members and no deputies. Jeppe Øvlesen currently owns 55 000 shares in Cereno Scientific.“I am very happy about the prospect of welcoming Jeppe Øvlesen to the board of Cereno. He has a wealth of experience from